Scarica l'app Stockscreener
6.11
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$6.11
Aprire:
$6.08
Volume 24 ore:
3.62M
Relative Volume:
0.80
Capitalizzazione di mercato:
$1.47B
Reddito:
$386.15M
Utile/perdita netta:
$-56.39M
Rapporto P/E:
-26.57
EPS:
-0.23
Flusso di cassa netto:
$-55.19M
1 W Prestazione:
+2.35%
1M Prestazione:
+38.08%
6M Prestazione:
+20.75%
1 anno Prestazione:
+0.99%
Intervallo 1D:
$6.08
$6.29
Intervallo di 1 settimana:
$5.7809
$6.29
Portata 52W:
$3.21
$7.18
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.11 | 1.40B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
How Ardelyx Inc. stock performs during market volatility2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
Multi asset correlation models including Ardelyx Inc.Gap Down & Verified Stock Trade Ideas - Newser
Analyzing net buyer seller activity in Ardelyx Inc.Portfolio Value Report & Technical Confirmation Trade Alerts - Newser
Applying chart zones and confluence areas to Ardelyx Inc.Fed Meeting & Daily Market Momentum Tracking - Newser
Volume spikes in Ardelyx Inc. stock – what they mean2025 Institutional Moves & Real-Time Volume Analysis - Newser
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Live market analysis of Ardelyx Inc.July 2025 Update & Fast Gain Swing Alerts - Newser
Will Ardelyx Inc. benefit from macro trendsWeekly Trade Recap & High Conviction Investment Ideas - Newser
Why Ardelyx (ARDX) Is Up 10.6% After Raising IBSRELA Sales Outlook and Reporting Strong Q2 Revenue - simplywall.st
Can you recover from losses in Ardelyx Inc.Rate Cut & Reliable Intraday Trade Alerts - Newser
What candlestick patterns are forming on Ardelyx Inc.Weekly Stock Analysis & AI Based Trade Execution Alerts - Newser
Ardelyx Inc. stock trend outlook and recovery pathMarket Volume Summary & Smart Investment Allocation Insights - Newser
Statistical indicators supporting Ardelyx Inc.’s strengthEarnings Trend Report & Trade Opportunity Analysis Reports - Newser
Why Ardelyx Inc. is moving todayPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - Newser
Will Ardelyx Inc. outperform the marketMarket Activity Report & AI Forecast for Swing Trade Picks - Newser
Automated trading signals detected on Ardelyx Inc.Weekly Gains Report & Weekly Setup with High ROI Potential - Newser
What makes Ardelyx Inc. stock price move sharply2025 Analyst Calls & Growth Focused Entry Reports - Newser
Tools to assess Ardelyx Inc.’s risk profileMarket Performance Summary & Weekly Breakout Stock Alerts - Newser
Visual trend scoring systems applied to Ardelyx Inc.July 2025 Weekly Recap & Low Risk High Reward Trade Ideas - Newser
Ardelyx (ARDX) Appoints New Chief Business and HR Officers - MSN
Ardelyx Inc. Breaks Below Key Support LevelMarket Activity Report & Daily Technical Forecast Reports - 선데이타임즈
Pattern Scan Adds Ardelyx Inc. to WatchlistJuly 2025 Catalysts & High Accuracy Buy Signal Tips - sundaytimes.kr
Ardelyx's Accelerating Revenue Growth and Strategic Momentum in 2025: A Deep Dive into IBSRELA's Surge and XPHOZAH's Resilience - AInvest
Ardelyx: Improved Outlook For Ibsrela And Xphozah (NASDAQ:ARDX) - Seeking Alpha
Ardelyx (ARDX) Is Up 10.6% After Raising 2025 IBSRELA Sales Guidance and Posting Strong Q2 Results - simplywall.st
Blair William & Co. IL Boosts Stake in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Ardelyx Inc. Flashes Rebound Signal in Oversold Condition2025 Earnings Surprises & Community Consensus Stock Picks - beatles.ru
Ardelyx Inc. stock trend outlook and recovery path [Earnings Growth Summary]Fast Exit Strategy with Risk Control - Newser
Is Ardelyx Inc. exposed to currency risksFree Stock Market Entry Signals - thegnnews.com
Ardelyx (ARDX) Is Up 20.3% After Raising IBSRELA Sales Guidance and Announcing Leadership ChangesWhat's Changed - simplywall.st
Ardelyx Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Can Ardelyx’s (ARDX) Leadership Changes and Raised Guidance Reshape Its Long-Term Growth Prospects? - simplywall.st
Piper Sandler Maintains a Hold Rating on Ardelyx (ARDX) - MSN
Little Excitement Around Ardelyx, Inc.'s (NASDAQ:ARDX) Revenues As Shares Take 26% Pounding - 富途牛牛
Ardelyx Q2 Revenue Jumps 33% - AOL.com
Understanding Ardelyx Inc.’s price movementSmart Entry Signals for Active Traders - Newser
Ardelyx raises 2025 IBSRELA revenue guidance to $250M–$260M amid sustained demand growth - MSN
Ardelyx Inc. Faces Financial Uncertainty Amid Shifting Trade Policies - The Globe and Mail
Ardelyx Inc. Q2 2025 Earnings Call Highlights - The Globe and Mail
Ardelyx price target raised to $9 from $8 at Piper Sandler - TipRanks
Insiders Of Ardelyx Are Up 20% On Their US$6.78m Purchase - 富途牛牛
Ardelyx, Inc. (NASDAQ:ARDX) Q2 2025 Earnings Call Transcript - Insider Monkey
Ardelyx Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Ardelyx Inc Faces Uncertainty Amid Shifting Trade Policies - AInvest
BTIG Remains a Buy on Ardelyx (ARDX) With a $14 PT - MSN
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming - MSN
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming By Stocktwits - Investing.com India
Ardelyx Surpasses Expectations with Remarkable Q2 Performance - timothysykes.com
Ardelyx Stock Soars: Time to Buy? - StocksToTrade
Wedbush Raises Price Target on Ardelyx to $14 From $13, Keeps Outperform Rating - MarketScreener
Ardelyx shares rise 13.21% premarket after reporting strong Q2 revenue growth and raising 2025 sales expectations. - AInvest
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ardelyx Inc Azioni (ARDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MOTT DAVID M | Director |
Jun 09 '25 |
Buy |
3.69 |
200,000 |
737,260 |
2,696,871 |
| Williams Laura A | Chief Medical Officer |
May 20 '25 |
Sale |
4.08 |
6,421 |
26,207 |
402,583 |
| Renz Justin A | Chief Financial Officer |
May 20 '25 |
Sale |
4.08 |
7,218 |
29,460 |
416,089 |
| RAAB MICHAEL | President & CEO |
May 20 '25 |
Sale |
4.08 |
46,817 |
191,079 |
1,547,937 |
| Kelliher Mike | See Remarks |
May 20 '25 |
Sale |
4.08 |
14,522 |
59,270 |
282,158 |
| GRAMMER ELIZABETH A | See Remarks |
May 20 '25 |
Sale |
4.08 |
5,992 |
24,456 |
311,731 |
| Foster Eric Duane | Chief Commercial Officer |
May 20 '25 |
Sale |
4.08 |
2,507 |
10,232 |
316,806 |
| MOTT DAVID M | Director |
May 15 '25 |
Buy |
3.29 |
100,000 |
329,120 |
2,496,871 |
| MOTT DAVID M | Director |
May 02 '25 |
Buy |
4.22 |
381,377 |
1,610,936 |
2,396,871 |
| RAAB MICHAEL | President & CEO |
May 02 '25 |
Option Exercise |
0.99 |
20,833 |
20,625 |
1,636,420 |
0.94%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):